Southbay Pharma Research Report issue

For profit Phase 2
Founded: Buena Park CA United States (2005)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2005
NCT00108810
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

ketoprofen (orudis) (1 trial)

Drugs in Other Trials (1)

aox blend (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2